Publication Name	World Journal of Diabetes
Manuscript ID	64629
Country	Italy

Received	2021-02-28 21:00
Peer-Review Started	2021-02-28 21:11
To Make the First Decision
Return for Revision	2021-07-15 18:37
Revised	2021-09-14 21:52
Second Decision	2022-02-21 07:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-02-23 20:57
Articles in Press	2022-02-23 20:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-03-08 17:57
Publish the Manuscript Online	2022-03-15 14:23

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Markers of insulin resistance in Polycystic ovary syndrome women: An update
Manuscript Source	Invited Manuscript
All Author List	Chantal Anifa Amisi
Funding Agency and Grant Number
Corresponding Author	Chantal Anifa Amisi, MD, PhD, Doctor, Senior Researcher, Endocrinology and Diabetes Unit, Department of Medicine, Universita Campus Bio-medico di Rome, via alvaro del portillo 21, Rome 00128, Italy. chantalamisi@yahoo.fr
Key Words	Markers; Insulin resistance; Polycystic ovary syndrome; Emerging markers; Impaired glucose tolerance
Core Tip	Diagnosing insulin resistance in Polycystic ovary syndrome is of crucial importance for better management and prevention of complications. Seeking of an easy-to-detect surrogate marker of insulin resistance represents a promising approach for maximizing treatment outcomes. This review highlights markers of insulin resistance already used in women with Polycystic ovary syndrome, including new markers recently reported in literature, and establishes a new classification of them.
Publish Date	2022-03-15 14:23
Citation	Amisi CA. Markers of insulin resistance in Polycystic ovary syndrome women: An update. World J Diabetes 2022; 13(3): 129-149
URL	https://www.wjgnet.com/1948-9358/full/v13/i3/129.htm
DOI	https://dx.doi.org/10.4239/wjd.v13.i3.129

Full Article (PDF)	WJD-13-129.pdf
Full Article (Word)	WJD-13-129.docx
Manuscript File	64629_Auto_Edited.docx
Answering Reviewers	64629-Answering reviewers.pdf
Audio Core Tip	64629-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	64629-Conflict-of-interest statement.pdf
Copyright License Agreement	64629-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	64629-Language certificate.pdf
Peer-review Report	64629-Peer-review(s).pdf
Scientific Misconduct Check	64629-Bing-Liu M-1.png
Scientific Misconduct Check	64629-Bing-Wang LL-2.png
Scientific Editor Work List	64629-Scientific editor work list.pdf